Wells Fargo Upgrades Charles River Labs (CRL) to Outperform on Major Sell-Off
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/16/2026
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Netflix earnings forecast disappoints Wall Street, shares tumble
- Alphabet stock falls on report of Gemini AI model delays
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil settles lower, but remains near one-month high on U.S.-Iran tension
JPMorgan Upgrades Charles River Labs (CRL) to Overweight
December 13, 2012 7:26 AM ESTJPMorgan upgraded Charles River Labs (NYSE: CRL) from to Overweight with a price target of $42.00 (from $40.00).
NOTE: This is the second upgrade of CRL today and follows yesterday's 9% sell-off on 2013 guidance.
For an analyst ratings summary and ratings... More
Charles River Labs (CRL) Guides FY13 EPS Below Views
December 12, 2012 7:34 AM ESTCharles River Laboratories International, Inc. (NYSE: CRL) provided guidance for 2013 and reaffirmed guidance for 2012.
James C. Foster, Chairman, President and Chief Executive Officer, said, The actions we have taken in the last three years to enhance our in vivo biology portfolio, improve our operating efficiency, and forge stronger... More
